Evidence map›Paper›PMID 29511634›Full record

ArticleAsian journal of urology2014

Prostate cancer in Asia: A collaborative report.

Rui Chen, Shancheng Ren, Chinese Prostate Cancer Consortium, Ming Kwong Yiu, Ng Chi Fai, Wai Sam Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah Kehinde and 37 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asian journal of urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03891732 (The Use of MRI Prostate in Improving Detection of Significant Prostate Cancer in a Screening Population of Chinese Men With Elevated PSA), which is not on this map. Cited by 101 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03891732 active not recruitingnot on this mapstarted 2019, after this paper: background citation

The Use of MRI Prostate in Improving Detection of Significant Prostate Cancer in a Screening Population of Chinese Men With Elevated PSA

TypeobservationalSponsorChinese University of Hong KongRan2019 to 2024Enrolled690ConditionsProstate Cancer, PSA, MRIArmsMRI prostate
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Prevalence and clinical application ofAsian journal of andrology
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Possible Roles for Purinergic Receptor P2RX4 in Breast and Prostate Cancers.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Rui ChenDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Shancheng RenDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Chinese Prostate Cancer Consortium
Ming Kwong YiuDivision of Urology, Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Ng Chi FaiDivision of Urology, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Wai Sam ChengUrology Centre, Singapore General Hospital, Singapore.
Lap Hong IanDepartment of Urology, Centro Hospitalar Conde de São Januário (CHCSJ) Hospital, Macau, China.
Seiji NaitoDepartment of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tadashi MatsudaDepartment of Urology and Andrology, Hirakata Hospital, Kansai Medical University, Osaka, Japan.
Elijah KehindeDepartment of Surgery, Kuwait University, Kuwait.
Ali KuralDepartment of Urology, Istanbul Acibadem University, Istanbul, Turkey.
Jason Yichun ChiuDepartment of Urology, Taipei City Hospital, National Yang-Ming University, Taipei, Taiwan, China.
Rainy UmbasDivision of Urology, Department of Surgery, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Qiang WeiDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Xiaolei ShiDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Liqun ZhouDepartment of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, Beijing, China.
Jian HuangDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Yiran HuangRenji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Liping XieDepartment of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Lulin MaDepartment of Urology, Peking University Third Hospital, Beijing, China.
Changjun YinState Key Laboratory of Reproductive Medicine, Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Danfeng XuDepartment of Urology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Kexin XuPeking University People's Hospital, Beijing, China.
Zhangqun YeDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chunxiao LiuDepartment of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Dingwei YeFudan University Shanghai Cancer Center and Department of Oncology, Shanghai, China.
Xin GaoDepartment of Urology, 3rd Hospital of Sun Yat-Sen University, Guangzhou, China.
Qiang FuShanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
Jianquan HouThe First Affiliated Hospital of Soochow University, Suzhou, China.
Jianlin YuanDepartment of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Dalin HeDepartment of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Tiejun PanDepartment of Urology, Wuhan General Hospital of Guangzhou Military Command, Wuhan, China.
Qiang DingDepartment of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Fengshuo JinDepartment of Urology, Daping Hospital, Chongqing, China.
Benkang ShiDepartment of Urology, Qilu Hospital of Shandong University, Jinan, China.
Gongxian WangDepartment of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Xiuheng LiuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan, China.
Dongwen WangDepartment of Urology, First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
Zhoujun ShenDepartment of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Xiangbo KongDepartment of Urinary Surgery, China-Japan Union Hospital, Jilin University, Changchun, China.
Wanhai XuDepartment of Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.
Yaoliang DengThe First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Haibo XiaDepartment of Urology, Affiliated Hospital of Chifeng College, Chifeng, China.
Alexa N CohenDepartment of Molecular and Medical Pharmacology, University of California, Los Angeles, CA, USA.
Xu GaoDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Chuanliang XuDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.
Yinghao SunDepartment of Urology, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of prostate cancer (PCa) within Asian population used to be much lower than in the Western population; however, in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCa diagnosis, current status and new trends in surgery management and novel agents for castration-resistant prostate cancer. We believe such information would be helpful in clinical decision making for urologists and oncologists, health-care ministries and medical researchers.

Indexed as

Asian populationEpidemiologyProstate cancerRacial differencesRisk factorsSurgery management

Identifiers

PMID29511634
PMCPMC5832886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.